What debilitating condition affects 1.5 million women in the UK, and yet takes almost nine years on average to be diagnosed? A condition that – despite the numbers it affects – is so poorly recognised that it is often mistaken for something else, or written off as unimportant? That results in pain so bad it […]
For decades, scientists believed that infections were determined solely by viruses and bacteria, but Professor Jean-Laurent Casanova’s groundbreaking research has revealed a more complex reality. Genes play a fundamental role in determining who gets seriously ill and who stays healthy. Because of his pioneering discoveries, he is being honoured and awarded with the 2025 Novo […]
Access to rare disease medicines will likely always be a fraught issue as healthcare systems seek to balance providing equitable patient care against their finite budgets. Even so-called “universal” healthcare systems, such as the NHS, are often unable to provide expensive rare disease treatments to the patients that need them because of costs and the […]
OZEMPIC, Wegovy, Mounjaro, Zepbound: they’ve quickly become part of our vocabulary. In just a few years, powerful GLP-1 drugs, first introduced to control Type 2 diabetes but now much better known for their ability to help people rapidly lose weight, have become indispensable weapons in the Battle of the Bulge. In the UK alone, some […]
We hope you are enjoying Optimum’s weekly newsletter – subscribe on LinkedIn today so you never miss an edition. Our clients Loqus23 Therapeutics and Ona Therapeutics continued the stream of good news for February with key leadership appointments. LoQus23 Therapeutics appoints Cyrus Mozayeni MD to Chair of the Board of Directors LoQus23 Therapeutics Ltd, […]
